OncoScreen-R Rapid Test
OncoScreen-R: Rapid test for colorectal and pancreatic cancers.
OncoScreen-R Rapid Test
Rapid Test for Colorectal and Pancreatic Cancer Detection
Overview:
OncoScreen-R is a high-performance lateral flow rapid test developed by OncoFirm Diagnostics, designed for the early detection of colorectal and pancreatic cancers. Leveraging the specificity of Thomsen-Friedenreich (TF) and Gal-GalNAc antigens, OncoScreen-R delivers accurate, reliable results in under 15 minutes using a small sample of blood, serum, or plasma.
Key Features:
- Cancer-Specific Antigens: Targets TF and Gal-GalNAc antigens, which are overexpressed in gastrointestinal and pancreatic tumors.
- Non-Invasive & Rapid: Requires minimal sample volume with results available at the point-of-care within minutes.
- High Sensitivity & Specificity: Engineered with enhanced nanoparticle signal amplification for accurate results.
- Ideal for Medical Institutions: Designed for hospitals, clinics, diagnostic labs, and oncology screening programs.
- Digital Integration-Ready: Compatible with smartphone apps and digital readers for real-time data collection and analysis.
Clinical Applications:
- Early screening for colorectal cancer (CRC) and pancreatic adenocarcinoma
- Risk assessment in patients with family history or pre-malignant GI symptoms
- Adjunct to imaging and endoscopy in underserved or resource-limited settings
- Monitoring of at-risk populations in oncology and gastroenterology clinics
Ce que propose magical spin dépasse la simple addition de jeux : il s’agit d’un véritable cadre construit pour durer. Les paramètres de notification se configurent finement selon les souhaits du joueur. Une sélection d’exclusivités contractuelles avec certains studios crée un attrait supplémentaire. L’application des plafonds journaliers se fait de manière transparente et configurable. Les partenaires logiciels intégrés sont systématiquement passés au crible de la sécurité. Les variantes de roulette en direct s’étendent de la classique européenne aux versions Lightning et Speed. Les réponses par email parviennent généralement dans la journée pour les demandes standards. Le mode portrait offre une lisibilité supérieure pour les rouleaux verticaux des slots. Les missions hebdomadaires apportent une couche ludique supplémentaire qui plaît aux joueurs réguliers. L’expérience laisse une trace positive qui se confirme à chaque nouvelle visite.
Benefits to Healthcare Providers:
- Enhances early diagnosis in high-risk patients
- Reduces diagnostic delays in clinical settings
- Supports personalized treatment planning and follow-up strategies
Next Steps:
OncoScreen-R is currently available for CE-marked markets and undergoing further clinical validation. U.S. FDA regulatory pathways are in progress.
